Specific inhibition of acetylcholinesterase as an approach to decrease muscarinic side effects during myasthenia gravis treatment. [electronic resource]
Producer: 20181123Description: 304 p. digitalISSN:- 2045-2322
- Animals
- Cholinesterase Inhibitors -- adverse effects
- Humans
- Intestines -- drug effects
- Muscle Contraction
- Muscle, Smooth -- drug effects
- Myasthenia Gravis, Autoimmune, Experimental -- drug therapy
- Pyridostigmine Bromide -- adverse effects
- Quaternary Ammonium Compounds -- adverse effects
- Rats
- Uracil -- adverse effects
- Urinary Bladder -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.